Intended for healthcare professionals

Clara Hellner

Clara Hellner earned her M.D. in 1987 and her Ph.D. in 2001, both at Karolinska Institutet (KI) in Stockholm. She is a clinical specialist in child- and adolescent psychiatry, and was appointed adjunct professor in child and adolescent psychiatry in 2016. Since 2012, she holds a position as Director of the Stockholm Centre for Psychiatry Research and deputy head of Department of Clinical Neuroscience at KI.

Previous positions include head of Section of Forensic Psychiatry (2002-2007) and deputy head of another department at KI. During 2008-2011, she served as Dean of Doctoral Education at KI. The Dean is the chair of the Board of Doctoral Education, responsible for a yearly budget of 180 MSEK, and also part of the steering group of the university. During this time, Clara Hellner also was appointed chair of the International Strategy group at KI, which is a committee serving the Vice Chancellor of Karolinska Institutet, responsible for all issues related to international strategic collaboration.

Her research has focused on young people with neurodevelopmental disorders such as ADHD and autism, and their relation to negative psychosocial outcomes of such disorders (e.g. self-harm, antisocial behaviours and substance misuse).

Apart from academic appointments, Clara Hellner has served in various boards and research committees, such as the World’s Children’s Prize for the Rights of the Child, the National commission on substance abuse, and the Swedish Crime Victim Compensation and Support Authority. She is frequently engaged as a speaker on issues related to child victimization and child norm breaking behavior.

I have the following interests to declare:

My current position is Director of Research and Innovation in the leadership of Region Stockholm, the main provider of public health care and public transportation in the greater Stockholm area. I am also adjunct professor in child- and adolescent psychiatry at Karolinska Institutet. Part of my role as Director implies heading the Centre for Health Data in Region Stockholm. We provide test beds for industry who wish to make use of health data from the region’s health care system, together with clinical staff in our health care system. For each test bed we write an agreement. The common model is that industry financially supports the analyses (provided by eg a CRO). No money is transferred to the health care sector. I am involved in the capacity of my position.

At the Centre for Health Data, we have developed a joint agreement with industrial trade organisations (Pharma, Medtech, Labtech etc) on how to collaborate in a transparent matter (e.g. in test beds described above). I was responsible for the process of establishing these work models.

I am part of the board of Karolinska Institutet Holding, a university owned (state) company supporting researchers who aim to commercialize their research. For this I receive a reimbursement of about 25 000 SEK/year. I am not directly involved in scouting or supporting ideas; as part of the board Ioversee the company’s work including its finances, policies, etc.

I am part of the board of Stockholm Science City, a foundation focused on integrating the three major universities in Stockholm with Region Stockholm and the City of Stockholm. No reimbursement.

I am part of the board of Cancer Centre Karolinska, a foundation dedicated to supporting clinical cancer research in Stockholm. No reimbursement.

I am part of the board of Thuring’s foundation, dedicated to supporting research on mental health. I review applications and take part in the decision process on which projects shall be funded. A reimbursement of 30 000 SEK/year is provided.

I am part of the board and head of the scientific committee for Queen Silvia’s Jubilee Foundation for research on children and handicap. No reimbursement.

From time to time, I do expert assignments for various research institutions or universities. Such assignments are usually reimbursed with a fixed fee.